Ozturk, K. Et Al. 2017. Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.517 , 157-167.

Ozturk, K., ESENDAĞLI, G., Gurbuz, M. U., TÜLÜ, M., & ÇALIŞ, S., (2017). Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.517, 157-167.

Ozturk, Kivilcim Et Al. "Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers," INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.517, 157-167, 2017

Ozturk, Kivilcim Et Al. "Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers." INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.517, pp.157-167, 2017

Ozturk, K. Et Al. (2017) . "Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers." INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.517, pp.157-167.

@article{article, author={Kivilcim Ozturk Et Al. }, title={Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers}, journal={INTERNATIONAL JOURNAL OF PHARMACEUTICS}, year=2017, pages={157-167} }